{
    "Trade/Device Name(s)": [
        "IMMULITE 2000 Third Generation TSH",
        "IMMULITE 2000 Free T4"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K160647",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083373",
        "K970227"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW",
        "CEC"
    ],
    "Summary Letter Date": "March 4, 2016",
    "Summary Letter Received Date": "March 7, 2016",
    "Submission Date": "May 3, 2016",
    "Regulation Number(s)": [
        "21CFR862.1690",
        "21CFR862.1695"
    ],
    "Regulation Name(s)": [
        "Thyroid stimulating hormone test system",
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid stimulating hormone (TSH)",
        "Free thyroxine (T4)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2000 Systems Analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2000 Third Generation TSH and Free T4 assays with updated pediatric reference intervals",
    "Indications for Use Summary": "For quantitative measurement of thyrotropin (TSH) in serum and nonprotein-bound thyroxine (free T4) in serum and heparinized plasma, used in the diagnosis of thyroid or pituitary disorders and treatment of thyroid disease",
    "fda_folder": "Clinical Chemistry"
}